Literature DB >> 19744582

Thrombospondin-2 regulates matrix mineralization in MC3T3-E1 pre-osteoblasts.

Andrea I Alford1, Shawn P Terkhorn, Anita B Reddy, Kurt D Hankenson.   

Abstract

The matricellular protein thrombospondin-2 (TSP2) has context-dependent effects on osteoblast lineage proliferation and differentiation. Mice lacking TSP2 display increased endocortical bone thickness, which is associated with increased marrow stromal cell (MSC) number and in vitro proliferation. TSP2-null MSC also exhibit delayed osteoblastogenesis and enhanced adipogenesis compared to cells harvested from wild type mice. The goal of the present work was to more precisely characterize the contribution that TSP2 makes to the maturation of osteoblast-derived extracellular matrix (ECM) using a highly characterized pre-osteoblast cell line. Specifically, we asked whether TSP2 influences mineralization indirectly through its known effects on proliferation, or whether TSP2 directly promotes osteoblast differentiation. To pursue these questions, we used RNA-interference (RNAi) to inhibit TSP2 gene expression in MC3T3-E1 pre-osteoblasts. Introduction of siRNA oligonucleotides resulted in reduced TSP2 mRNA expression as early as 24 h post-transfection, and TSP2 mRNA levels remained low for 10 days. Similarly, TSP2 protein levels in both conditioned medium and the cell-matrix layer were reduced at 24 h post-transfection and remained reduced for 7 days. At day 21, mineralization was significantly reduced in cells transfected with TSP2 siRNA when compared to cells treated with scrambled siRNA. This decrease in mineralization occurred without a concomitant change in cell number. Twenty-four hours after transfection, runx2 gene expression was transiently enhanced in TSP2 siRNA-treated cultures. Between 6 and 14 days post-transfection, runx2, osterix, alkaline phosphatase, type I collagen, osteocalcin and bone sialoprotein all displayed moderate increases in gene expression with TSP2 RNAi. As well, soluble osteocalcin levels were markedly higher in the conditioned medium of cells treated with TSP2 siRNA than in control siRNA-treated cells. Increased soluble osteocalcin occurred without a concomitant change in the levels of osteocalcin in the cell-ECM layer. TSP2 reduction also elicited a transient change in the distribution of collagen between the acid soluble cell-ECM protein fraction and the insoluble matrix. Together, our data suggest that TSP2 may promote mineralization, by facilitating proper organization of the osteoblast-derived ECM. (c) 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19744582      PMCID: PMC2818128          DOI: 10.1016/j.bone.2009.08.058

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  31 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Constitutive expression of thrombospondin 1 in MC3T3-E1 osteoblastic cells inhibits mineralization.

Authors:  Akemichi Ueno; Yoshihiro Miwa; Keiko Miyoshi; Taigo Horiguchi; Hideo Inoue; Intan Ruspita; Kaori Abe; Kikuji Yamashita; Eiji Hayashi; Takafumi Noma
Journal:  J Cell Physiol       Date:  2006-11       Impact factor: 6.384

3.  Nucleation of hydroxyapatite by bone sialoprotein.

Authors:  G K Hunter; H A Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

4.  Reduced expression of thrombospondins and craniofacial dysmorphism in mice overexpressing Fra1.

Authors:  Toru Nishiwaki; Toru Yamaguchi; Chen Zhao; Hitoshi Amano; Kurt D Hankenson; Paul Bornstein; Yoshiaki Toyama; Koichi Matsuo
Journal:  J Bone Miner Res       Date:  2006-04-05       Impact factor: 6.741

5.  The secreted protein thrombospondin 2 is an autocrine inhibitor of marrow stromal cell proliferation.

Authors:  Kurt D Hankenson; Paul Bornstein
Journal:  J Bone Miner Res       Date:  2002-03       Impact factor: 6.741

6.  Thrombospondin-1 induces matrix metalloproteinase-2 activation in vascular smooth muscle cells.

Authors:  Taeseung Lee; Nowokere Esemuede; Bauer E Sumpio; Vivian Gahtan
Journal:  J Vasc Surg       Date:  2003-07       Impact factor: 4.268

7.  Thrombospondin 2 regulates cell proliferation induced by Rac1 redox-dependent signaling.

Authors:  Neuza Lopes; David Gregg; Sanjay Vasudevan; Hamdy Hassanain; Pascal Goldschmidt-Clermont; Hervé Kovacic
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

8.  Transcriptional regulation of osteoblasts.

Authors:  Renny T Franceschi; Chunxi Ge; Guozhi Xiao; Hernan Roca; Di Jiang
Journal:  Cells Tissues Organs       Date:  2008-08-27       Impact factor: 2.481

9.  Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures.

Authors:  W Liu; S Toyosawa; T Furuichi; N Kanatani; C Yoshida; Y Liu; M Himeno; S Narai; A Yamaguchi; T Komori
Journal:  J Cell Biol       Date:  2001-10-01       Impact factor: 10.539

10.  Thrombospondin 2 inhibits microvascular endothelial cell proliferation by a caspase-independent mechanism.

Authors:  Lucas C Armstrong; Benny Björkblom; Kurt D Hankenson; Anthony W Siadak; Charlotte E Stiles; Paul Bornstein
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

View more
  23 in total

Review 1.  Thrombospondins and novel TSR-containing proteins, R-spondins, regulate bone formation and remodeling.

Authors:  Kurt D Hankenson; Mariya T Sweetwyne; Hailu Shitaye; Karen L Posey
Journal:  Curr Osteoporos Rep       Date:  2010-06       Impact factor: 5.096

2.  Thrombospondin-2 deficiency in growing mice alters bone collagen ultrastructure and leads to a brittle bone phenotype.

Authors:  Eugene Manley; Joseph E Perosky; Basma M Khoury; Anita B Reddy; Kenneth M Kozloff; Andrea I Alford
Journal:  J Appl Physiol (1985)       Date:  2015-08-13

3.  Two molecular weight species of thrombospondin-2 are present in bone and differentially modulated in fractured and nonfractured tibiae in a murine model of bone healing.

Authors:  Andrea I Alford; Anita B Reddy; Steven A Goldstein; Prithvi Murthy; Riyad Tayim; Gorav Sharma
Journal:  Calcif Tissue Int       Date:  2012-02-24       Impact factor: 4.333

Review 4.  Thrombospondin-2 and extracellular matrix assembly.

Authors:  Nicole E Calabro; Nina J Kristofik; Themis R Kyriakides
Journal:  Biochim Biophys Acta       Date:  2014-01-15

Review 5.  Cartilage oligomeric matrix protein: COMPopathies and beyond.

Authors:  Karen L Posey; Francoise Coustry; Jacqueline T Hecht
Journal:  Matrix Biol       Date:  2018-03-09       Impact factor: 11.583

6.  Fabrication of 3D Scaffolds with Precisely Controlled Substrate Modulus and Pore Size by Templated-Fused Deposition Modeling to Direct Osteogenic Differentiation.

Authors:  Ruijing Guo; Sichang Lu; Jonathan M Page; Alyssa R Merkel; Sandip Basu; Julie A Sterling; Scott A Guelcher
Journal:  Adv Healthc Mater       Date:  2015-06-29       Impact factor: 9.933

7.  Thrombospondin-2 is an endogenous adipocyte inhibitor.

Authors:  Hailu S Shitaye; Shawn P Terkhorn; Jason A Combs; Kurt D Hankenson
Journal:  Matrix Biol       Date:  2010-05-31       Impact factor: 11.583

Review 8.  The thrombospondins.

Authors:  Josephine C Adams; Jack Lawler
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-10-01       Impact factor: 10.005

9.  Loss of Nmp4 optimizes osteogenic metabolism and secretion to enhance bone quality.

Authors:  Yu Shao; Emily Wichern; Paul J Childress; Michele Adaway; Jagannath Misra; Angela Klunk; David B Burr; Ronald C Wek; Amber L Mosley; Yunlong Liu; Alexander G Robling; Nickolay Brustovetsky; James Hamilton; Kylie Jacobs; Deepak Vashishth; Keith R Stayrook; Matthew R Allen; Joseph M Wallace; Joseph P Bidwell
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-01-15       Impact factor: 4.310

10.  Osteoblast-released Matrix Vesicles, Regulation of Activity and Composition by Sulfated and Non-sulfated Glycosaminoglycans.

Authors:  Johannes R Schmidt; Stefanie Kliemt; Carolin Preissler; Stephanie Moeller; Martin von Bergen; Ute Hempel; Stefan Kalkhof
Journal:  Mol Cell Proteomics       Date:  2015-11-23       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.